We estimate that the CEO of LEMAITRE VASCULAR INC ($LMAT), George W. LeMaitre, received a compensation of $3,780,990 in 2025. This is an increase of 14.43% from an estimated $3,235,558 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 14, 2026. Note that parsing errors may occur.
You can track $LMAT on Quiver Quantitative's $LMAT stock dashboard.
$LMAT Stock Insider Trading Activity
$LMAT Stock insiders have traded $LMAT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $LMAT stock by insiders over the last 6 months:
- GEORGE W LEMAITRE (Chairman and CEO) has made 0 purchases and 2 sales selling 205,930 shares for an estimated $22,043,375.
- DAVID B ROBERTS (President and Director) has made 0 purchases and 2 sales selling 11,775 shares for an estimated $1,260,543.
- TRENT G KAMKE (Senior V. P., Operations) has made 0 purchases and 2 sales selling 3,669 shares for an estimated $399,955.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LMAT Stock Government Contracts
We have seen $282,099 of award payments to $LMAT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROSTHETICS - HEART ARTERY: $47,158
- DENTAL IMPLANT: $31,985
- CRYO-VEIN: $23,108
- PROSTHETIC: RESTOREFLOW SAPHENOUS VEIN ALLOGRAFT 75 - 79 CM: $21,748
- FEMORAL ARTERY: $16,038
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$LMAT Stock Hedge Fund Activity
We have seen 139 institutional investors add shares of $LMAT Stock stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- M&T BANK CORP added 381,061 shares (+2240.5%) to their portfolio in Q4 2025, for an estimated $30,904,047
- PRICE T ROWE ASSOCIATES INC /MD/ removed 238,310 shares (-45.1%) from their portfolio in Q4 2025, for an estimated $19,326,941
- CONESTOGA CAPITAL ADVISORS, LLC removed 149,700 shares (-9.5%) from their portfolio in Q4 2025, for an estimated $12,140,670
- FIRST TRUST ADVISORS LP added 111,193 shares (+13.4%) to their portfolio in Q4 2025, for an estimated $9,017,752
- GEODE CAPITAL MANAGEMENT, LLC added 105,921 shares (+20.1%) to their portfolio in Q4 2025, for an estimated $8,590,193
- CONGRESS ASSET MANAGEMENT CO added 102,198 shares (+14.0%) to their portfolio in Q1 2026, for an estimated $11,156,955
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 100,920 shares (-37.9%) from their portfolio in Q4 2025, for an estimated $8,184,611
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LMAT Stock Price Targets
Multiple analysts have issued price targets for $LMAT recently. We have seen 4 analysts offer price targets for $LMAT in the last 6 months, with a median target of $111.0.
Here are some recent targets:
- Nathan Treybeck from Wells Fargo set a target price of $94.0 on 02/26/2026
- Daniel Stauder from Citizens set a target price of $118.0 on 02/26/2026
- Kyle Bauser from Roth Capital set a target price of $117.0 on 02/26/2026
- Michael Petusky from Barrington Research set a target price of $105.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
